| P.O.Box 2345, Beijing 100023,China | World J Gastroenterol 2003 Feb 15;9(2):338-341 |
| Email: wjg@wjgnet.com | WJG ISSN 1007-9327 CN 14-1219/ R |
| http:// www.wjgnet.com | Copyright © 2003 by The WJG Press |
Influence of platelet activating factor on expression of adhesion molecules in experimental pancreatitis
Hua Zhao, Ji-Wei Chen, Ya-Kui Zhou, Xue-Feng Zhou, Pei-Yun Li
Hua Zhao, Ji-Wei Chen, Ya-Kui
Zhou, Xue-Feng Zhou, Department of
general surgery, Zhongnan ospital, Wuhan University, Wuhan 430071, Hubei
Province, China
Pei-Yun Li,
Department of Pathology, Medical school, Wuhan University, Wuhan 430071, Hubei
Province, China
Correspondence to: Dr.
Hua Zhao, Department of general surgery,Zhongnan hospital, Wuhan University,
Wuhan 430071, Hubei Province, China. jhonazao@yahoo.com.cn
Telephone:
+86-27-87330104
Received:
2002-08-13 Accepted: 2002-09-02
Abstract
AIM: To determine whether Platelet
activating factor (PAF) has a regulation role in the expression of adhesion
molecules and accumulation of neutrophils in a murine model of acute
pancreatitis.
METHODS: One
hundred twenty-eight Kunming mice were divided into four groups. Group 1
received 0.1 ml saline s.c. every hour for three hours (sham). Group 2 received
cerulein (50 mg/kg dose s.c.) every hour for three hours. Group 3 received AP
and additional challenge of PAF (50 mg/kg in absolute ethanol) (AP/PAF). Group 4
received AP, plus therapeutic treatment with GAB (25 mg dose i.p.) immediately
after the first challenge of cerulein (AP/GAB). Animals were sacrificed at 12 h
after the first challenge of saline or cerulein. Adhesion molecules of pancreas
were semi-quantified by SP methods. Standard assays were performed for serum
amylase and myeloperoxidase activity (MPO) of pancreas. Histology of pancreas
was scored in a blind manner. Water content of pancreas was also measured at the
same time.
RESULTS: Control
pancreata showed negligible adhesion molecule expression and neutrophil
accumulation. There were evident adhesion molecules expression and neutrophil
accumulation in AP and AP/PAF compared with sham (P<0.05). AP/GAB had
a lower level of adhesion molecules, neutrophils, and water content versus AP
and AP/PAF (P<0.05). Histology showed a trend toward improvement in
AP/GAB, but did not reach statistical significance.
CONCLUSION: PAF
can induce the expression of adhesion molecules that mediate neutrophil
accumulation. The PAF antagonist reduces the expression of adhesion molecules
and the severity of inflammation when given immediately after the induction of
mild AP in mice. These results suggest that PAF antagonism may be useful in the
treatment of mild pancreatitis after its clinical onset.
Zhao H, Chen JW, Zhou YK, Zhou XF, Li PY. Influence of platelet activating
factor on expression of adhesion molecules in experimental pancreatitis.
World J Gastroenterol 2003; 9(2):338-341
http://www.wjgnet.com/1007-9327/9/338.htm
INTRODUCTION
Acute pancreatitis (AP) was
characterized as local and systemic inflammatory reactions. Adhesion molecules
play a pivotal role in neutrophil immigration and accumulation[1].
Platelet activating factor (PAF) is a biologically active phospholipid which is
thought to function as one of the proximal mediators in the inflammatory cascade
of AP. However, the relationship between PAF and the expression of adhesion
molecules in AP remains largely unknown, although Blackstone MO has ever
speculated[2].
The present study was conducted
to determine whether PAF has a regulatory role in the expression of adhesion
molecules and the accumulation of neutrophils. To examine this effect, a murine
model of edematous pancreatitis was established by overdose administration of
cerulein, as described by Tani et al[3]. PAF and its
antagonist (GAB) were also used in this experiment.
MATERIALS AND METHODS
Meterials
Cerulein and PAF were purchased from
Sigma Chemical Co. (St.Louis, Missouri). GAB (Ginkgolide AB) was a generous gift
from associate professor Di-Qing Zhang in Guizhou University. MPO assay kit was
purchased from Nanjing Jiancheng Bioengineering Co. Ltd. China. Rabbit anti-rat
E-selectin polyclonal antibody and Rabbit anti-rat ICAM-1 polyclonal antibody
were purchased from Boster Bioengineering Co. Ltd. China. SP assay kit was
purchased from Maixin Bioengineering Co. Ltd. China. Cerulein was dissolved in
normal saline at the concentration of 10 mg/ml.
PAF was first dissolved in absolute ethanol, and then diluted with normal saline
when it was to be used. GAB was dissolved in 30 % Dimethyl Sulfoxide (DMSO).
128 six-week-old Kunming
mice, weighing 34-36 g each, were purchased from the experimental animal center
of Wuhan University. The animals were randomly divided into 4 groups (described
in methods) and fed standard laboratory chow. All animals were allowed to
acclimatize for a minimum of 1 week prior to experimentation. Before the day of
the experiment, animals were fasted overnight, but allowed free access to water.
Animals model
Acute pancreatitis was established
in 32 mice (AP group) by subcutaneous injection of cerulein (50 mg/kg
dose) every hour for three hours. Sham group (32 mice) received subcutaneous
injection of normal saline every hour for three hours. AP/PAF group (32 mice)
received subcutaneous injection of cerulein (50 mg/kg
dose) every hour for three hours, plus PAF (50 mg/kg
dose) injected peritoneally immediately after the first cerulein challenge.
AP/GAB group (32 mice) received subcutaneous injection of cerulein (50 mg/kg
dose) every hour for three hours, plus therapeutic treatment with GAB (25 mg/kg
i.p.) immediately after the first cerulein challenge.
The animals were
sacrificed at 12 h after the first cerulein challenge or saline injection. Some
mice (eight in every group) were decapitated and the blood was collected in
vials for the analysis of serum amylase. Pancreata were dissected. Some were
weighted and grounded for the analysis of MPO, and the others were fixed with
formalin for histological scoring and immunohistochemical staining. Some left
pancreatic tissues were dried and weighted.
MPO measurement
MPO assay of pancreas was
performed according to the instructions of commercial kit.
Amylase
Serum amylase levels were
measured using starch-iodine method.
Water content
Pancreas was dissected from its
attachment and the fluid on its surface was dried with filter paper. Then the
pancreas was placed in oven at a temperature of 90-92 ℃
for 10 hours. Water content = (Weightwet-Weightdry)/ Weightwet?00 %.
Histological grading
Pancreatic sections were stained
with hematoxilin and eosin and graded in a blind manner by two investigators.
Severity of pancreatitis was scored on a scale of 0 to 4 (normal to severity) in
the categories (vacuolization, inflammation, edema) for a total score of 0 to
12, as described by J.Schmidt[4].
Immunohistochemical staining
Pancreata were fixed in formalin for
12 h and then embedded in paraffin wax. Sections were cut at 4 mm in thickness
and mounted on slides. They were deparaffinized by passing them through two
changes of xylene and graded series of ethanol, followed by rinses in tap water
and 0.01 mmol.l-1
phosphorate buffered saline (PBS),respectively. Endogenous peroxidase activity
was quenched by treating the section with 3 % hydrogen peroxide for 10 minutes.
Nonspecific binding was blocked by incubating sections in 1 % bovine albumin in
PBS for 10 minutes, and then incubated for an hour in primary antibody (rabbit
anti-E-selectin or rabbit anti-ICAM-1 polyclonal antibody). After rinsing in
PBS, the sections were treated sequentially with biotinconjugated second
antibody for 10 minutes and then with streptavidin-peroxidase for another 10
minutes with PBS rinsing after each step. Sections were stained subsequently
with freshly prepared DAB reagent for 3 minutes, and terminated by rinsing in
water. then the sections were immerged in hematoxylin for 3-5 minutes and 0.5
mmol.l-1
HCl for 10 seconds. Finally, when passed through two changes of xylene and
graded series of alcohol, the sections were covered with coverslip for light
analysis. Every slice was counted on ten different fields by two investigators
independently. Vessel stained brown was considered positive vessel. (-), score
0, means no positive vessel was observed. (+), score 1, means 1-2 positive
vessels were observed. (++), score 2,means 3-4 positive vessels were observed.
(+++), score 3, means more than 5 positive vessels were observed.
Statistical analysis
Numerical variables are
reported as means ±SEM
and compared between groups using Newman-Keuls method. Rank data are
reported as means and analyzed with Nemenyi method. Difference with P<0.05
are considered significant.
RESULTS
Expression of adhesion molecules
In control group there was no
staining of E-selectin and ICAM-1 in pancreatic venules. Expression of the two
adhesion molecules was eminent in AP and AP/PAF. But there was no difference
between the two groups. AP/GAB has a lower level of E-selectin and ICAM-1
expression compared with AP (Table 1, Figures 1-4).
Figure
1 12 h, sham group showed negative
expression of adhesion molecules. (×400).
Figure
2 E-selectin was evident in AP at 12
h. (×400).
Figure
3 ICAM-1 was evident in AP at 12 h.
(×400).
Figure
4 ICAM-1 expression in AP/GAB at 12
h. (×400).
Amylase and water content
Serum amylase levels and water
content was used to evaluate the severity of pancreatic injury. Amylase rose at
12 h in AP and AP/PAF group against control group, but there was no difference
between the two groups. GAB treatment significantly reduced the amylase level at
12 h (P<0.05). Water content reflects the extent of pancreatic edema.
At 12 h AP and AP/PAF showed a higher level of water content against sham and
AP/GAB. AP/GAB still has a higher level of water content than sham (Table 2).
MPO activity
Measurement of neutrophil
accumulation by MPO activity revealed that AP and AP/PAF had an increase of MPO
activity almost 10-fold greater than sham. AP/GAB showed significantly lower
level of MPO Activity than AP (P<0.05). And this level did not return
to the values seen in sham treated animals (Table 2).
Pancreatic histological analysis
Sham group was microscopically
intact, with normal histological structure. Pancreatic lesions, such as edema,
vacuation and infiltration of PMN were found in AP, AP/PAF and AP/GAB. There was
a trend toward improvement in histological parameters in AP/GAB, but it failed
to reach statistical significance. (Data not shown).
Table 1
Expression of adhesion molecules in pancreas. (x±s)
| Group | E-selectin | ICAM-1 |
| Sham | 0 | 0 |
| AP | 2.1a | 2.3a |
| AP/PAF | 2.3a | 2.4a |
| AP/GAB | 1.1b | 1.1b |
aP<0.05 vs
sham, bP<0.05 vs AP.
Table 2 Measurement
of amylase, MPO activity, water content.(x±s).
| Group | Amylase (×103 U/L) | MPO activity (AU/g) | Water content (%) |
| Sham | 4.2±0.2 | 2.14±0.011 | 71.0±0.1 |
| AP | 22.1±2.7a | 2.213±0.035a | 81.0±0.2a |
| AP/PAF | 22.9±0.9a | 2.325±0.067a | 79.8±0.2a |
| AP/GAB | 10.9±0.8b, c | 0.795±0.004b,c | 75.3±0.1b,c |
aP<0.05, bP<0.05
vs sham, cP<0.05 vs AP.
DISCUSSION
Platelet activating factor,
1-O-octadecyl-2-acetyl-Sn-glycero-3-phosphocholine, is a potent inflammatory
mediator produced by endothelial cells, platelets, monocytes, neutrophils, and
basophils. It has been widely studied that PAF played an important role in the
pathogenesis of AP, and its local and systemic effects on AP have also been
revealed. The systemic effects cause circulatory disturbances and multiple organ
failure. Local effects include platelet aggregation, neutrophil accumulation,
microvascular ischemia and increasing of capillary permeability[5-7].
Moreover, PAF itself also can induce pancreatitis when injected in peritoneal or
superior pancreatoduodenal artery[8-10].
Accordingly, treatment of
experimental pancreatitis with PAF antagonist has consistently shown significant
local and systemic protection to reduce inflammatory changes[11-15].
But the mechanism of its protection has not been fully classified. One kind of
PAF antagonist, lexipafant, has been studied in clinical trials in acute
pancreatitis. In phase II and phase III clinical studies lexipafant showed
better protection against AP, although a phase III clinical trial in UK showed
little protection in the treatment of severe acute pancreatitis[16-18].
In vitro PAF can induce
the expression of adhesion molecules[19], there was little
information whether PAF and its antagonist could regulate the expression of
adhesion molecules in AP. So, we conducted this experiment to testify the
hypothesis.
Leukocyte accumulation from
circulating blood to the site of inflammation includes multiple steps involving
different kind of adhesion molecules on the endothelial cell. There are four
steps in the adhesion cascade: (1) tethering, (2) triggering, (3) firm adhesion
and (4) diapedesis- and these steps must occur in ordered sequence. Tethering
interactions are the first step in the adhesion cascade. The molecules involved
in this reaction come from the selectin family, such as E-selectin and P-selectin.
The firm-binding phase involves superimmunoglobulin family, such as ICAM-1 and
VCAM-1. Both E-selectin and ICAM-1 have shown to be necessary for
transendothelial migration of polymorphonuclear leukocytes[20]. In
AP, neutrophils and adhesion molecules elevate and play an important role[21,22].Treatment
of severe acute pancreatitis with ICAM-1 monoclonal antibody reduces
the severity of pancreatic and lung injury. The severity of AP is partially
decreased in mice deficient in ICAM-1[22].
In our study adhesion molecules
were elevated in AP. But additional PAF challenge couldn't
increase the expression of adhesion
molecules. PAF antagonist (GAB) can reduce the expression of adhesion molecules
and reduce the accumulation of neutrophils in pancreas in AP. The mechanism may
be that internal PAF has enough capability to induce the expression of adhesion
molecule, and exogenous PAF do not have accelerating ability to induce more
expression of adhesion molecules. PAF antagonist may have different ways in AP
to reduce the expression of adhesion molecules: (1) reduce the concentration of
cytokines, such as TNF-a
and IL-1b[23,24].
(2) reduce oxidative stress in pancreas[24,25]. (3) repress the
activation of NF-kB directly.
In conclusion, PAF plays an
important role in the expression of adhesion molecules and accumulation of
neutrophils in AP. PAF antagonist can be used early in mild AP. Further studies
are necessary to determine whether PAF antagonist can prevent mild AP to
transform into severe AP.
ACKNOWLEDGEMENT
We gratefully acknowledge associate
Prof. Di-Qing Zhang for his precious PAF antagonist (GAB).
REFERENCES
1
Albelda
SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J
1994; 8: 504-512
2 Blackstone MO. ICAM-1incerulein-induced pancreatitis.
Gastroenterology 1999; 117: 748-749
3 Tani S, Otsuki M, Itoh H, Fujii M, Nakamura T, Oka T,
Baba S. Historic and biochemical alterations in experimental
pancreatitis by supermaximal caerulein
stimulation. Int J Pancreatol 1987;2: 337-348
4 Schmidt J, Lewandrowski K, Fernandez-del Castillo C,
Mandavilli U, Compton CC, Warshaw AL, Rattner DW.
Histopathologic correlation of serum amylase
activity in acute experimental pancreatitis. Dig Dis Sci 1992; 37:
1426-1433
5 Johnson CD. Platelet-activating factor and
Platelet-activating factor antagonists in acute pancreatitis. Dig
Surg 1999; 16: 93-101
6 Zhao LY, Chen CY, Liang P, Chen LY. ICAM-1 and VCAM-1
expressions on benign gastric mucosa and gastric
adenocarcinoma associated with Helicobacter
pylori infection. Shijie Huaren Xiaohua Zazhi 2000; 8: 279-281
7 Zhao XY, Xia SH. Platelet-activating factor and onset
and treatment of acute pancreatitis. Shijie Huaren Xiaohua
Zazhi 2001; 9: 958-960
8 Konturek SJ, Dembinski A, Konturek PJ, Warzecha Z,
Jaworek J, Gustaw P, Tomaszewska R, Stachura J. Role of
platelet activating factor in pathogenesis of
acute pancreatitis in rats. Gut 1992;33: 1268-1274
9 Kald B, Kald A, Ihse I, Tagesson C. Release of
platelet- activating factor in acute experimental pancreatitis.
Pancreas 1993; 8: 440-442
10 Emanuelli G, Montrucchio G, Gaia E, Dughera L, Corvetti G,
Gubetta L. Experimental pancreatitis induced by platelet
activating factor in rabbits. Am J Pathol 1989; 134:
315-326
11 Werner J, Z'raggen K,
Fernandez-del-Castillo C, Lewandrowski KB, Compton CC, Warshaw AL. Specific
therapy for local
and systemic complications of acute pancreatitis
with monoclonal antibodies against ICAM-1. Ann Surg 1999; 229: 834-840
12 Rau B, Barer A, Eber S, Gansauge F, Poch B, Beger HG, Moller P.
Anti-ICAM-1 antibody modulates last onset of acinar
cell apoptosis and early necrosis in taurocholate-induced
experimental acute pancreatitis. Panereas 2001; 23: 80-88
13 Rau B, Bauer A, Wang A, Gansauge F, Weidenbach H, Nevalainen T,
Poch B, Beger HG, Nussler AK. Modulation of
endogenous nitric oxide synthase in experimental
acute pancreatitis:role of anti-ICAM-1 and oxygen free radlical
scavengers. Ann Surg 2001; 233: 195-203
14 Eibl G, Buhr HJ, Foitzik T. Therapy for microcirculatory
disorders in severe acute pancreatitis:what mediators should we
block?Intensive Care Med 2002; 28: 139-146
15 Lundberg AH, Fukatsu K, Gaber L, Callicutt S, Kotb M, Wilcox H,
Kudsk K, Gaber AO. Blocking pulmonary ICAM-1
expression ameliorates lung injury in established
diet-induced pancreatitis. Ann Surg 2001; 233: 213-220
16 Kingsnorth AN, Galloway SW, Formela LJ. Randomized,
double-blind, phase II trial of Lexipafant, a platelet-activating
factor antagonist in human acute pancreatitis. Br
J Surg 1995; 82: 1414-1420
17 McKay CJ, Curran F, Sharples C, Baxter JN, Imrie CW. Prospective
placebo-controlled randomized trail of Lexipafant
in predicted severe acute pancreatitis. Br J Surg
1997; 84: 1239-1243
18 Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP,
McKay C, Toh SK, Skaife P, Leeder PC, Wilson P,
Larvin M, Curtis LD. Double blind, randomized,
placebocon-trolled study of a PAF-antagonist, Lexipafant, in treatment
and prevention of organ failure in predicted SAP.
Gut 2001; 48: 62-69
19 Chihara J, Maruyama I, Yasaba H, Yasukawa A, Yamamoto T, Kurachi
D, Mouri T, Seguchi M, Nakajima S. Possible induction
of intercellular adhesion molecule-1 (ICAM-1)
expression on endothelial cells by platelet-activating factor (PAF). J Lipid
Mediat 1992; 5: 159-162
20 Butcher EC, Picker LJ. Lymphocyte homing and hemeostasis.
Science 1996; 272: 60-66
21 Zaninovic V, Gukovskaya AS, Gukovsky I, Mouria M, Pandol SJ.
Cerulein upregulates ICAM-1 in pancreatic acinar cells,
which mediates neutrophil adhesion to these
cells. Am J Physiol Gastrointest Liver Physiol 2000; 279: G666-676
22 Frossard JL, Saluja A, Bhagat L, Lee HS, Bhatia M, Hofbauer B,
Steer ML. The role of intercellular adhesion molecule 1
and neutrophils in acute pancreatitis and
pancreatitis-associated lung injury. Gastroenterology 1999; 116: 694-701
23 Luscinskas FW, Cybulsky MI, Kiely JM, Peckins CS, Davis VM,
Gimbrone MA Jr. Cytokine-activated human
endothelial monolayers support enhanced
neutrophil transmigration via a mechanism involving both endothelial-
leukocyte adhesion molecule-1 and intercellular
adhension molecule-1. J Immunol 1991; 146: 1617-1625
24 Lane JS, Todd KE, Gloor B, Chandler CF, Kau AW, Ashley SW, Reber
HA, McFadden DW. Platelet activating factor
antagonism reduces the systemic inflammatory
response in a murine model of acute pancreatitis. J Surg
Res 2001; 99: 365-370
25 Wang WX, Zhao HP, Shou NY, Yang CW. Role of oxygen free radical
and other inflammatory mediators in acute
necrotic pancreatitis. World J Gastroenterol
1998; 4 (Suppl 2): 59
Edited by Zhou YP